• BGI Plans IPO for BGI Tech

    Bloomberg News | BGI Tech, part of BGI, is planning a $400 initial public offering. The IPO will take place in Hong Kong.

    Feb 21, 2014

  • Bold Claims as GenapSys Opens Early Access to GENIUS

    Bio-IT World News Brief | Last week at AGBT 2014, GenapSys opened an early access program for researchers to test out the company's GENIUS sequencer, an instrument the size of a tablet that the company claims will be highly competitive on both speed and cost.

    Feb 19, 2014

  • Novel Encryption Scheme Aims to Secure Genetic Data

    ScienceNow | Kristin Lauter of Microsoft has demonstrated a new security scheme for genetic data that allows the data to be mined for information while still encrypted.

    Feb 19, 2014

  • N-of-One and Appistry Announce Partnership

    Boston Business Journal | N-of-One and Appistry have partnered to more easily bring N-of-One's diagnostics plans to health care organizations.

    Feb 18, 2014

  • Patient Stratification in Clinical Trials Emerges as Theme at MMTC

    Bio-IT World | The 21st annual Molecular Medicine Tri-Conference in San Francisco featured some intense scrutiny of one area where genetic knowledge is ready to make an impact today: better defining the best patient populations for treatment during clinical trials.

    Feb 17, 2014

  • Illumina Launches Genomics Accelerator

    Xconomy | Illumina is creating a genomics-focused accelerator at its Mission Bay R&D facility under construction in San Francisco.

    Feb 13, 2014

  • GenomOncology Announces Collaborations, Partnerships Before AGBT

    Bio-IT World | GenomOncology has announced several collaborations and partnerships surrounding its step-by-step workflow that takes raw data from the sequencer and translates the molecular profile of each patient’s tumor genome into an actionable clinical report. Recent partnerships include Roswell Park Cancer Institute, Vanderbilt-Ingram Cancer Center, University of Pittsburgh, and CompanionDx.

    Feb 12, 2014

  • QuantuMDx Launches MolDx Indiegogo Campaign

    Bio-IT World | QuantuMDx is taking their handheld molecular diagnostic tool to the masses, and hoping to raise $50,000 in an Indiegogo campaign starting today. The money will support a malaria clinical trial in Africa. 

    Feb 12, 2014